We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

French Researchers Developing Key NanoArrayer™ Applications

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

BioForce Nanosciences has announced the placement of a NanoArrayer in Paris at the Universite Pierre & Marie Curie (UPMC) for technology evaluation by CNRS (Centre National de la Recherche Scientifique), the French National Center for Scientific Research.

The NanoArrayer was installed in May in the laboratory of Dr. Fatiha Nothias who noted, "Our plan is to use the unique printing capabilities of the NanoArrayer to pattern proteins associated with cell morphology establishment and migration."

Dr Nothias said, "Our end goal is to determine the consequences of the interactions of neurons and glial cells with these patterned proteins."

Other French research groups in the same institute have expressed interest in utilizing the NanoArrayer to study how cells sense their environment during the organization of the embryonic tissue.

Michael Lynch, Product Manager for the NanoArrayer, assisted with the installation and training process.

He noted that, "The NanoArrayer enables protein patterning in the significantly small dimensions required to study single cell growth and development important in Neuroscience, Cancer Biology, Stem Cell Research, Genetic Disease and more."

Lynch added, "This installation also provided an opportunity to introduce NanoAndMore, our European distributor for the NanoArrayer product line, to these new and exciting markets."

"This technology agreement partnership with UPMC and CNRS provides BioForce with valuable new market applications of the NanoArrayer," noted Kerry Frey, BioForce COO.

"Our goal is continued growth into emerging new bionanotechnology markets in Europe and this placement, our second overseas this year, continues our progress."